1,3,4-Oxadiazole Scaffold in Medicinal Chemistry: A Review of Pharmacological Applications and Structure–Activity Relationships

Author(s): Israa Ali Abbas
Date: 09/10/2026
doi: https://doi.org/10.5281/zenodo.8425890

---

Abstract

The 1,3,4-oxadiazole framework represents a useful heterocyclic nucleus in medicinal chemistry due to 
its structural flexibility, good bioisosteric characteristics and the breadth of biological activities reported. 
These scaffold derivatives have demonstrated promising anticancer, antimicrobial, anti-inflammatory, 
antitubercular, antiviral, anticonvulsant, and antidiabetic activity such that they are potential leads in drug 
discovery and optimization (Ali et al., 2022; Amini & Vosoogh, 2023; Polat et al., 2024). This review will 
assess the recent developments in the synthesis, pharmacological uses, structure-activity relationships, and 
rational design approaches of 1,3,4-oxadiazole derivatives. A structured literature-based review method 
was used, focusing on peer-reviewed studies that reported synthetic approaches, biological evaluation, 
SAR interpretation, and computational support for oxadiazole-based compounds. The synthesis methods 
reviewed consist of classical cyclodehydration, one-pot, oxidative annulation, microwave-assisted, 
solvent-free, and other green chemistry methods (Li et al., 2025; Pathak et al., 2019; Unresolved source 
55, n.d.). The core results suggest that replacement at the 2- and 5-positions of the oxadiazole ring, and 
conjugation with bioactive pharmacophores have a potent effect on potency, selectivity, and interaction 
with targets (Chaudhari et al., 2021; Li et al., 2025; Mandal et al., 2020). It is also found that 1,3,4
oxadiazole derivatives often correlate with enzyme inhibition, anticancer effects, antimicrobial effects, 
and inflammatory processes. Their contribution towards target based design is also supported through 
molecular docking studies that determine likely binding modes and critical ligand-protein interactions. 
Overall, 1,3,4-oxadiazole is an extremely promising drug discovery scaffold, but needs further refinement 
to achieve better selectivity, toxicity, pharmacokinetics, and experimental validation to enhance its 
translational capability.

---